Oral biologics are medications that are taken by mouth and are derived from or contain biological components. These medications are used to treat a variety of conditions, such as autoimmune diseases, cancer, and certain infections. They differ from traditional medications in that they are made up of living cells, proteins, or other biological molecules.

Unlike traditional medications such as pills and injections, oral biologics work differently in the body. They are designed to act on specific targets inside the body, rather than just delivering a single active ingredient. For example, some oral biologics are designed to target a particular protein that triggers a disease process. These medications can be used to reduce inflammation, stop the growth of cancer cells, or even stimulate the immune system to fight infection.

The A2Z Market Research report on “Global Oral Biologics Market Report 2023 – Future Opportunities, Latest Trends, In-depth Analysis, and Forecast To 2030” offers strategic visions into the global Oral Biologics market along with the market size (Volume – Million Units and Revenue – US$ Billion) and estimates for the duration 2023 to 2030. The research study covers an in-depth analysis of multiple market segments based on type, application, and studies of different topographies. The report also includes competitive profiling of the leading Oral Biologics product vendors and their latest developments.

This report has been segmented by type, application, and geography and includes the market size and forecast for all these segments. Compounded annual growth rates for all segments have also been provided for 2023 to 2030. The study highlights current market trends for Oral Biologics and provides future trends that will impact the demand. Year-on-year growth rates are also provided for each segment covered in the global Oral Biologics market report. The report also analyzes the market from a production perspective. It includes raw material cost analysis, technology cost analysis, labor cost analysis, and cost overview for the Oral Biologics market.

By geography, the market has been segmented into North America, South America, Asia, Europe, Africa, and Others. Under North America, the report covers the United States and Canada, whereas Asia includes China, Japan, India, Korea, and Southeast Asia. The key countries covered under Europe include Germany, the United Kingdom, France, and Russia, whereas ‘Others’ comprises the Middle East and GCC countries. The present market size and forecast till 2030 for all the regions and sub-regions have also been provided in the report.

This report covers the Major Players’ data, including shipment, revenue, gross profit, interview record, and business distribution; these data help the consumer better understand the competitors. It also includes a competitive scenario in the market. It offers insights into the manufacturer share from 2015 to 2018 in shipment and revenue for all major players identified in the global Oral Biologics market. Other key parameters include plant location, technology source, downstream industry, and contact information.

Some of the important players in the Oral Biologics market are:

Novo Nordisk A/S

Biocon Limited

Oramed Pharmaceuticals, Inc.

Rani Therapeutics

Entera Bio Ltd.

AbbVie Inc.

Enteris BioPharma Inc.

Chiasma Inc.

Allena Pharmaceuticals Inc.

Concord Biotech

Aurobindo Pharma Ltd.

Lundbeck A/S

Sanofi-Aventis

Roche

Type

Video

Voice

Text

Hybrid

Segmentation by Application

Educational Institutes

Corporate

Online Course Providers

Global Oral Biologics Market Research Report 2023 - Future Opportunities, Latest Trends, In-depth Analysis, and Forecast To 2030

 

Chapter 1 Oral Biologics Market Overview

1.1 Product Overview and Scope of Oral Biologics

1.2 Oral Biologics Market Segmentation by Type

1.2.1 Global Production Market Share of Oral Biologics by Type in 2020

1.2.1 Type 1

1.2.2 Type 2

1.2.3 Type 3

1.3 Oral Biologics Market Segmentation by Application

1.3.1 Oral Biologics Consumption Market Share by Application in 2020

1.3.2 Application 1

1.3.3 Application 2

1.3.4 Application 3

1.4 Oral Biologics Market Segmentation by Regions

1.4.1 North America

1.4.2 China

1.4.3 Europe

1.4.4 Southeast Asia

1.4.5 Japan

1.4.6 India

1.5 Global Market Size (Value) of Oral Biologics (2014-2030)

 

Chapter 2 Global Economic Impact on Oral Biologics Industry

2.1 Global Macroeconomic Environment Analysis

2.1.1 Global Macroeconomic Analysis

2.1.2 Global Macroeconomic Environment Development Trend

2.2 Global Macroeconomic Environment Analysis by Regions

 

Chapter 3 Global Oral Biologics Market Competition by Manufacturers

3.1 Global Oral Biologics Production and Share by Manufacturers (2020 and 2023)

3.2 Global Oral Biologics Revenue and Share by Manufacturers (2020 and 2023)

3.3 Global Oral Biologics Average Price by Manufacturers (2020 and 2023)

3.4 Manufacturers Oral Biologics Manufacturing Base Distribution, Production Area and Product Type

3.5 Oral Biologics Market Competitive Situation and Trends

3.5.1 Oral Biologics Market Concentration Rate

3.5.2 Oral Biologics Market Share of Top 3 and Top 5 Manufacturers

3.5.3 Mergers & Acquisitions, Expansion

 

Chapter 4 Global Oral Biologics Production, Revenue (Value) by Region (2014-2023)

4.1 Global Oral Biologics Production by Region (2014-2023)

4.2 Global Oral Biologics Production Market Share by Region (2014-2023)

4.3 Global Oral Biologics Revenue (Value) and Market Share by Region (2014-2023)

4.4 Global Oral Biologics Production, Revenue, Price and Gross Margin (2014-2023)

4.5 North America Oral Biologics Production, Revenue, Price and Gross Margin (2014-2023)

4.6 Europe Oral Biologics Production, Revenue, Price and Gross Margin (2014-2023)

4.7 China Oral Biologics Production, Revenue, Price and Gross Margin (2014-2023)

4.8 Japan Oral Biologics Production, Revenue, Price and Gross Margin (2014-2023)

4.9 Southeast Asia Oral Biologics Production, Revenue, Price and Gross Margin (2014-2023)

4.10 India Oral Biologics Production, Revenue, Price and Gross Margin (2014-2023)

 

Chapter 5 Global Oral Biologics Supply (Production), Consumption, Export, Import by Regions (2014-2023)

5.1 Global Oral Biologics Consumption by Regions (2014-2023)

5.2 North America Oral Biologics Production, Consumption, Export, Import by Regions (2014-2023)

5.3 Europe Oral Biologics Production, Consumption, Export, Import by Regions (2014-2023)

5.4 China Oral Biologics Production, Consumption, Export, Import by Regions (2014-2023)

5.5 Japan Oral Biologics Production, Consumption, Export, Import by Regions (2014-2023)

5.6 Southeast Asia Oral Biologics Production, Consumption, Export, Import by Regions (2014-2023)

5.7 India Oral Biologics Production, Consumption, Export, Import by Regions (2014-2023)

 

Chapter 6 Global Oral Biologics Production, Revenue (Value), Price Trend by Type

6.1 Global Oral Biologics Production and Market Share by Type (2014-2023)

6.2 Global Oral Biologics Revenue and Market Share by Type (2014-2023)

6.3 Global Oral Biologics Price by Type (2014-2023)

6.4 Global Oral Biologics Production Growth by Type (2014-2023)

 

Chapter 7 Global Oral Biologics Market Analysis by Application

7.1 Global Oral Biologics Consumption and Market Share by Application (2014-2023)

7.2 Global Oral Biologics Consumption Growth Rate by Application (2014-2023)

7.3 Market Drivers and Opportunities

7.3.1 Potential Applications

7.3.2 Emerging Markets/Countries

 

Chapter 8 Oral Biologics Manufacturing Cost Analysis

8.1 Oral Biologics Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Price Trend of Key Raw Materials

8.1.3 Key Suppliers of Raw Materials

8.1.4 Market Concentration Rate of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.2.1 Raw Materials

8.2.2 Labor Cost

8.2.3 Manufacturing Expenses

8.3 Manufacturing Process Analysis of Oral Biologics

 

Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers

9.1 Oral Biologics Industrial Chain Analysis

9.2 Upstream Raw Materials Sourcing

9.3 Raw Materials Sources of Oral Biologics Major Manufacturers in 2020

9.4 Downstream Buyers

 

Chapter 10 Marketing Strategy Analysis, Distributors/Traders

10.1 Marketing Channel

10.1.1 Direct Marketing

10.1.2 Indirect Marketing

10.1.3 Marketing Channel Development Trend

10.2 Market Positioning

10.2.1 Pricing Strategy

10.2.2 Brand Strategy

10.2.3 Target Client

10.3 Distributors/Traders List

 

Chapter 11 Market Effect Factors Analysis

11.1 Technology Progress/Risk

11.1.1 Substitutes Threat

11.1.2 Technology Progress in Related Industry

11.2 Consumer Needs/Customer Preference Change

11.3 Economic/Political Environmental Change

 

Chapter 12 Global Oral Biologics Market Forecast (2023-2030)

12.1 Global Oral Biologics Production, Revenue Forecast (2023-2030)

12.2 Global Oral Biologics Production, Consumption Forecast by Regions (2023-2030)

12.3 Global Oral Biologics Production Forecast by Type (2023-2030)

12.4 Global Oral Biologics Consumption Forecast by Application (2023-2030)

12.5 Oral Biologics Price Forecast (2023-2030)

 

Chapter 13 Appendix